ロード中...
The early onset of peripheral neuropathy might be a robust predictor for time to treatment failure in patients with metastatic breast cancer receiving chemotherapy containing paclitaxel
BACKGROUND: Paclitaxel plays a central role in chemotherapy for breast cancer. Peripheral neuropathy, a well-known toxicity with paclitaxel, may be of interest in predicting the efficacy of paclitaxel therapy for patients with metastatic breast cancer. We performed a retrospective analysis assessing...
保存先:
| 出版年: | PLoS One |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5595337/ https://ncbi.nlm.nih.gov/pubmed/28898275 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0184322 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|